TX-SOFTSERVE
27.10.2020 12:02:04 CET | Business Wire | Press release
SoftServe , a leading digital authority and consulting company and Premier Consulting Partner in the Amazon Web Services (AWS) Partner Network (APN), announces it has achieved AWS SaaS Competency status. The designation recognizes SoftServe’s experience helping organizations design and build Software-as-a-Service (SaaS) and cloud-native solutions on AWS.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201027005054/en/
In addition to the AWS SaaS Competency designation, SoftServe has also previously achieved AWS Data & Analytics Competency, AWS DevOps Competency, AWS Financial Services Competency, and AWS Retail Competency designations.
“By achieving AWS SaaS Competency status, we are committed to technical proficiency and customer success in the AWS Partner Network, enabling our clients with the most reliable and cost-effective SaaS solutions that are scalable, secure, and globally accessible,” said Andrew Greene - Associate Vice President, Global Partnerships & Alliances at SoftServe. “SoftServe has a proven track record of helping global organizations migrate, design, and build SaaS and cloud-native solutions on AWS through architecture reviews, technology R&D advisory services, security assessments; as well as full scope application migrations, modernizations, re-architectures, and new builds for enterprise and high-tech ISV clients.”
Using AWS and a well-architected multi-account strategy, Gotransverse and SoftServe implemented a multi-tenant SaaS solution to quickly develop and regularly update its customers’ services and components.
“SoftServe was instrumental in supporting our ability to automate the AWS data center creation process where we can go from nothing to a ready-to-provision data center with just a few keystrokes using Terraform and Ansible on top of the AWS API stack,” said Paul Tindall, CTO at Gotransverse. “Prior to this, building a new data center was very manual and error-prone. During this automation process, we were also able to go from self-managing services such as Redis and Elasticsearch to using AWS provided equivalents (Amazon ElastiCache and Amazon Elasticsearch). The development of this capability has more than paid for itself as we have expanded our geographic footprint across the globe with our launches of additional data centers in Australia, Europe, and North America. We look forward to working with SoftServe as we migrate our microservices layer to Amazon Kubernetes Service (Amazon EKS) and explore AWS artificial intelligence (AI) and machine learning (ML) offerings for enhancements to our product.”
AWS enables reliable, scalable, and secure solutions for startups to global enterprises. To support the seamless integration and deployment of these solutions, AWS established the AWS Competency Program to help customers identify Consulting and Technology APN Partners with deep industry experience and expertise. AWS SaaS Competency Partners help customers reduce friction when migrating off legacy applications and establish foundations required to build SaaS solutions successfully on AWS. They also write production application code and design and implement end-to-end solutions architecture for cloud-native products on AWS.
SoftServe’s Cloud-enabled services guide you from vision to execution in your SaaS journey, supporting key competencies in streamlined onboarding procedures, identity and access management, tenant isolation, and data partitioning. To learn more about SoftServe’s SaaS offerings on AWS, please visit www.softserveinc.com/en-us/aws-saas-enablement .
About SoftServe
SoftServe is a digital authority that advises and provides at the cutting-edge of technology. We reveal, transform, accelerate, and optimize the way enterprises and software companies do business. With expertise across healthcare, retail, energy, financial services, software, and more, we implement end-to-end solutions to deliver the innovation, quality, and speed that our clients’ users expect.
SoftServe delivers open innovation—from generating compelling new ideas, to developing and implementing transformational products and services. Our work and client experience is built on a foundation of empathetic, human-focused experience design that ensures continuity from concept to release. We empower enterprises and software companies to (re)identify differentiation, accelerate solution development, and vigorously compete in today’s digital economy. No matter where you are in your journey.
Visit our website , blog , LinkedIn , Facebook , and Twitter pages.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201027005054/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development27.4.2026 15:00:00 CEST | Press release
Phase 1 dose-escalation trial represents the first clinical trial of a product developed using the AraLinQ™ ADC technology and marks Taiho’s expansion into the clinical development of ADCs for oncology Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG (“Araris”) today announced that the U.S. Food and Drug Administration (FDA) has completed its Investigational New Drug (IND) review period for ARC-02, an antibody-drug conjugate (ADC) being developed for the treatment of non-Hodgkin lymphoma, enabling Taiho Oncology to initiate a Phase 1 dose-escalation clinical trial of ARC-02. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427127507/en/ Taiho Pharmaceutical acquired Araris Biotech in March 2025, expanding Taiho group’s capabilities in biologics and ADC research and development. Araris is a spin-off of the Paul Scherrer Institute and ETH in Switzerland focused on the development of antibody-drug co
Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 202627.4.2026 15:00:00 CEST | Press release
Premier global event to highlight how organizations are bringing data to life to power everything from AI to BI Boomi, the data activation company, today announced Boomi World 2026, its premier annual user conference, taking place May 11 - 14, 2026 in Chicago, IL. The event will bring together customers, partners, and industry leaders from around the world to explore how data activation is transforming the enterprise and accelerating the path to AI-driven outcomes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427600340/en/ Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 2026 Boomi World 2026 will spotlight data activation — bringing data to life to power AI, analytics, and intelligent automation. Attendees will gain firsthand insights into how the Boomi Enterprise Platform enables businesses to unify data, streamline operations, and innovate faster in an increasingly agentic world.
Axinn Appoints Rachael Philbin as Chief Innovation Officer27.4.2026 15:00:00 CEST | Press release
Appointment Reflects Firm's Vision for the Future of Legal Practice Axinn, Veltrop & Harkrider LLP today announced the appointment of Rachael Philbin as Chief Innovation Officer, reinforcing the firm’s continued investment in advanced solutions and technology for legal services delivery. Philbin joins from Proskauer Rose LLP, where she served as Innovation & Transformation Officer. Based in Axinn's New York office, she will lead the firm’s AI and legal technology initiatives as well as knowledge management efforts, accelerating adoption and integration across its antitrust, intellectual property, and litigation practices. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427277725/en/ Rachael Philbin joins Axinn, Veltrop & Harkrider LLP as Chief Innovation Officer. “As Axinn continues to grow, we are making deliberate investments in the capabilities that enable our lawyers to deliver service and results at the highest level
Seoul Viosys Eyes the $60 Billion AI Data Center Optical Communication Market with Opto Semiconductors27.4.2026 15:00:00 CEST | Press release
Joint Development Talks with Global Optical Communications companiesExpanding Partnerships to Provide Total Transceiver Solution1,800 Patents Secured for High-Performance Optical Communications Seoul Viosys (KOSDAQ: 092190), a company specializing in opto-semiconductor devices, is accelerating its entry into the next-generation photonics market supported by its proprietary “No-wire” and “No-package” fundamental patents—essential technologies for micrometer (μm)-scale miniaturization of opto-semiconductors—as well as its competitiveness in VCSEL technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260426926495/en/ Seoul Viosys Optoelectronic Semiconductor Structure Subject to a Permanent U.S. Injunction in February 2026, Covering Similar Products and Employees (Image: Seoul Viosys) As the rapid expansion of AI drives a paradigm shift in data centers from copper-based to optical-based architectures, the company is streng
vVARDIS Announces Investment from Apollo—Achieves Unicorn Status27.4.2026 14:51:00 CEST | Press release
Investment will support global commercial expansion of the Curodont™ technology platform, the first and only non-invasive peptide-containing formulations designed to treat tooth decay drill-free throughout the depth of the lesion vVARDIS Holding AG (“vVARDIS”), a high-growth dental medtech company pioneering non-invasive cavity treatment, today announced a strategic minority investment from Apollo-managed funds (“Apollo Funds”). The investment will support vVARDIS’ next phase of global growth and commercial expansion, including the continued rollout of its Curodont™ suite of products. The investment establishes vVARDIS as one of Europe’s few privately owned, billion-dollar-plus, healthcare companies. vVARDIS’ founders and co-CEOs, Drs. Haley and Goly Abivardi, will retain a substantial majority shareholding in the company. vVARDIS is redefining the treatment of cavities through its Curodont™ technology, the first and only commercially available non-invasive peptide-containing formulati
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
